Literature DB >> 9105522

Allergic cross-reactions between cat and pig serum albumin. Study at the protein and DNA levels.

C Hilger1, M Kohnen, F Grigioni, C Lehners, F Hentges.   

Abstract

After observing a patient allergic to cat dander and pork but devoid of other allergies, we prospectively screened patients known to be allergic to cat for a second sensitization to pork. After collecting the sera of 10 young patients found to contain specific IgE to cat dander and pork, we undertook this study to detect the possible cross-reactive allergen, define its molecular characteristics, and evaluate its clinical relevance. Through immunoblotting techniques, cat and porcine serum albumin were found to be jointly recognized molecules. These findings were further analyzed by specific anti-albumin IgE titrations and cross-inhibition experiments. Cat serum albumin cDNA was obtained from cat liver, and the corresponding amino acid sequence was deduced and compared to the known porcine and human serum albumin sequences. Inhibition experiments showed that the spectrum of IgE reactivity to cat serum albumin completely contained IgE reactivity to porcine serum albumin, suggesting that sensitization to cat was the primary event. In two cohorts of cat-allergic persons, the frequency of sensitization to cat serum albumin was found to lie between 14% and 23%. Sensitization to porcine albumin was found to lie between 3% and 10%. About 1/3 of these persons are likely to experience allergic symptoms in relation to pork consumption. Sensitization to cat serum albumin should be considered a useful marker of possible cross-sensitization not only to porcine serum albumin but also to other mammalian serum albumins.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9105522     DOI: 10.1111/j.1398-9995.1997.tb00972.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  28 in total

Review 1.  Emerging antigens involved in allergic responses.

Authors:  Thomas A E Platts-Mills; Scott P Commins
Journal:  Curr Opin Immunol       Date:  2013-10-03       Impact factor: 7.486

2.  Animal lipocalin allergens.

Authors:  Christiane Hilger; Annette Kuehn; Francois Hentges
Journal:  Curr Allergy Asthma Rep       Date:  2012-10       Impact factor: 4.806

Review 3.  Diagnosis and Management of Patients with the α-Gal Syndrome.

Authors:  Thomas A E Platts-Mills; Rung-Chi Li; Behnam Keshavarz; Anna R Smith; Jeffrey M Wilson
Journal:  J Allergy Clin Immunol Pract       Date:  2019-09-28

Review 4.  IgE in the diagnosis and treatment of allergic disease.

Authors:  Thomas A E Platts-Mills; Alexander J Schuyler; Elizabeth A Erwin; Scott P Commins; Judith A Woodfolk
Journal:  J Allergy Clin Immunol       Date:  2016-04-27       Impact factor: 10.793

Review 5.  Delayed anaphylaxis to red meat in patients with IgE specific for galactose alpha-1,3-galactose (alpha-gal).

Authors:  Scott P Commins; Thomas A E Platts-Mills
Journal:  Curr Allergy Asthma Rep       Date:  2013-02       Impact factor: 4.806

Review 6.  Red meat allergy in children and adults.

Authors:  Jeffrey M Wilson; Thomas A E Platts-Mills
Journal:  Curr Opin Allergy Clin Immunol       Date:  2019-06

7.  Cross-reactivity between aeroallergens and food allergens.

Authors:  Florin-Dan Popescu
Journal:  World J Methodol       Date:  2015-06-26

8.  Role of sensitization to mammalian serum albumin in allergic disease.

Authors:  Gennaro Liccardi; Riccardo Asero; Maria D'Amato; Gennaro D'Amato
Journal:  Curr Allergy Asthma Rep       Date:  2011-10       Impact factor: 4.806

Review 9.  Delayed anaphylaxis to red meat masquerading as idiopathic anaphylaxis.

Authors:  Anubha Tripathi; Scott P Commins; Peter W Heymann; Thomas A E Platts-Mills
Journal:  J Allergy Clin Immunol Pract       Date:  2014 May-Jun

10.  Initial description of pork-cat syndrome in the United States.

Authors:  Jonathon Posthumus; Hayley R James; Charles J Lane; Luis A Matos; Thomas A E Platts-Mills; Scott P Commins
Journal:  J Allergy Clin Immunol       Date:  2013-01-23       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.